Rimonabant Acomplia

Acomplia is a French diet drug that is produces by  Sanofi-Aventis (a popular drug company). This diet drug has proven itself to be strongly effective in helping people to lose weight. Although this medicine is generally prescribed to treat obesity, it can also be used in order to reduce the harmful risk factors that are related with weight and that could trigger severe medical desise (such as heart disorders).

Acomplia represents one of the latest and indeed one of the best ways for controlling body weight. Acomplia acts by being a cannabinoid receptor antagonist. This means that Acomplia prevents the normal action of endogenous cannabinoid located in the brain from stimulating the so-called CB1 receptors. It seems  that these receptors stimulate the desire to eat and because of that when they are “subdued” so is the need to eat. 

This diet drug first appeared in European Union pharmacies in 2006 and has quickly increased its popularity from that moment until now. Lots of clinical trials have proven that one of three patiens who have followed a treatment with Acomplia has been able to lose 25% of their body weight without gaining any kilos for in the next few years. Most people who have been treated with this drug lost  5 inches (48 pounds).

Acomplia also showed dramatic improvements also were reported in lipid profile with a 23% increase in HDL-cholesterol (good cholesterol) and a 15% decrease in triglycerides.

Improvements in glucose tolerance and insulin levels were also reported. Approximately half of the people diagnosed and participated at the studies with metabolic syndrome, who received the higher 20 mg daily dose of Acomplia, no longer had this condition at the conclusion of the trial.

If you buy Acomplia,the pill does not only facilitate the ability to control your weight, but fosters the ability to fend off weight gain.